[EN] INHIBITORS OF CYCLIN-DEPENDENT KINASES<br/>[FR] INHIBITEURS DE KINASES DÉPENDANTES DES CYCLINES
申请人:KINNATE BIOPHARMA INC
公开号:WO2021011796A1
公开(公告)日:2021-01-21
Provided herein are compounds which are inhibitors of cyclin-dependent kinases (CDKs), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity
申请人:UNIVERSITY OF MARYLAND, BALTIMORE COUNTY
公开号:US10058516B2
公开(公告)日:2018-08-28
The present invention is directed to compounds, methods and compositions for treating or preventing viral infections using nucleosides analogs. Specifically, the present invention provides for the design and synthesis of acyclic fleximer nucleoside analogues having increased flexibility and ability to alter their conformation structures to provide increased antiviral activity potential with the result of inhibiting several coronaviruses.
Provided herein are inhibitors of cyclin-dependent kinases (CDKs), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
DESIGN SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXIMER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY
申请人:University of Maryland, Baltimore County
公开号:EP3250564A2
公开(公告)日:2017-12-06
DESIGN, SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXMIER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY
申请人:UNIVERSITY OF MARYLAND, BALTIMORE COUNTY
公开号:US20180015052A1
公开(公告)日:2018-01-18
The present invention is directed to compounds, methods and compositions for treating or preventing viral infections using nucleosides analogs. Specifically, the present invention provides for the design and synthesis of acyclic fleximer nucleoside analogues having increased flexibility and ability to alter their conformation structures to provide increased antiviral activity potential with the result of inhibiting several coronaviruses.